378 related articles for article (PubMed ID: 20101235)
1. TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma.
Kupferman ME; Jiffar T; El-Naggar A; Yilmaz T; Zhou G; Xie T; Feng L; Wang J; Holsinger FC; Yu D; Myers JN
Oncogene; 2010 Apr; 29(14):2047-59. PubMed ID: 20101235
[TBL] [Abstract][Full Text] [Related]
2. Brain-Derived Neurotrophin and TrkB in Head and Neck Squamous Cell Carcinoma.
Dudás J; Riml A; Tuertscher R; Pritz C; Steinbichler TB; Schartinger VH; Sprung S; Glueckert R; Schrott-Fischer A; Johnson Chacko L; Riechelmann H
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641914
[TBL] [Abstract][Full Text] [Related]
3. Implications of tropomyosin-related kinase B (TrkB) in head and neck cancer.
Zhu L; Werner JA; Mandic R
Anticancer Res; 2007; 27(5A):3121-6. PubMed ID: 17970052
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma.
Bao W; Qiu H; Yang T; Luo X; Zhang H; Wan X
PLoS One; 2013; 8(7):e70616. PubMed ID: 23936232
[TBL] [Abstract][Full Text] [Related]
5. A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma.
Lee J; Jiffar T; Kupferman ME
PLoS One; 2012; 7(1):e30246. PubMed ID: 22276165
[TBL] [Abstract][Full Text] [Related]
6. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
[TBL] [Abstract][Full Text] [Related]
7. Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target.
Rasanen K; Sriswasdi S; Valiga A; Tang HY; Zhang G; Perego M; Somasundaram R; Li L; Speicher K; Klein-Szanto AJ; Basu D; Rustgi AK; Speicher DW; Herlyn M
Mol Cell Proteomics; 2013 Dec; 12(12):3778-92. PubMed ID: 24037664
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of the BDNF/TrKB pathway promotes epithelial-mesenchymal transition, as well as the migration and invasion of cervical cancer.
Yuan Y; Ye HQ; Ren QC
Int J Oncol; 2018 Feb; 52(2):461-472. PubMed ID: 29345295
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional profiling identifies upregulated genes following induction of epithelial-mesenchymal transition in squamous carcinoma cells.
Humtsoe JO; Koya E; Pham E; Aramoto T; Zuo J; Ishikawa T; Kramer RH
Exp Cell Res; 2012 Feb; 318(4):379-90. PubMed ID: 22154512
[TBL] [Abstract][Full Text] [Related]
10. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma.
St John MA; Dohadwala M; Luo J; Wang G; Lee G; Shih H; Heinrich E; Krysan K; Walser T; Hazra S; Zhu L; Lai C; Abemayor E; Fishbein M; Elashoff DA; Sharma S; Dubinett SM
Clin Cancer Res; 2009 Oct; 15(19):6018-27. PubMed ID: 19789323
[TBL] [Abstract][Full Text] [Related]
12. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
[TBL] [Abstract][Full Text] [Related]
13. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.
Lee TK; Poon RT; Wo JY; Ma S; Guan XY; Myers JN; Altevogt P; Yuen AP
Cancer Res; 2007 Sep; 67(18):8800-9. PubMed ID: 17875721
[TBL] [Abstract][Full Text] [Related]
14. Grape seed proanthocyanidins inhibit the invasive potential of head and neck cutaneous squamous cell carcinoma cells by targeting EGFR expression and epithelial-to-mesenchymal transition.
Sun Q; Prasad R; Rosenthal E; Katiyar SK
BMC Complement Altern Med; 2011 Dec; 11():134. PubMed ID: 22188922
[TBL] [Abstract][Full Text] [Related]
15. N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition.
Nguyen PT; Kudo Y; Yoshida M; Kamata N; Ogawa I; Takata T
Histol Histopathol; 2011 Feb; 26(2):147-56. PubMed ID: 21154228
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
17. G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway.
Xu R; Xu R; Wang Y; Wang W; Jiang L; Gong S
Comput Math Methods Med; 2022; 2022():6881932. PubMed ID: 35116073
[TBL] [Abstract][Full Text] [Related]
18. Uncovering the role of brain-derived neurotrophic factor/tyrosine kinase receptor B signaling in head and neck malignancies.
de Moraes JK; Wagner VP; Fonseca FP; Vargas PA; de Farias CB; Roesler R; Martins MD
J Oral Pathol Med; 2018 Mar; 47(3):221-227. PubMed ID: 28650560
[TBL] [Abstract][Full Text] [Related]
19. JunB promotes cell invasion, migration and distant metastasis of head and neck squamous cell carcinoma.
Hyakusoku H; Sano D; Takahashi H; Hatano T; Isono Y; Shimada S; Ito Y; Myers JN; Oridate N
J Exp Clin Cancer Res; 2016 Jan; 35():6. PubMed ID: 26754630
[TBL] [Abstract][Full Text] [Related]
20. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance.
Li T; Yu Y; Song Y; Li X; Lan D; Zhang P; Xiao Y; Xing Y
FASEB J; 2020 Jul; 34(7):9087-9101. PubMed ID: 32390303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]